These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
445 related items for PubMed ID: 27906180
1. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer. Wang X, Liang Z, Xu X, Li J, Zhu Y, Meng S, Li S, Wang S, Xie B, Ji A, Liu B, Zheng X, Xie L. Cell Death Dis; 2016 Dec 01; 7(12):e2503. PubMed ID: 27906180 [Abstract] [Full Text] [Related]
2. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis. Jili S, Eryong L, Lijuan L, Chao Z. Cell Biochem Funct; 2016 Dec 01; 34(8):597-605. PubMed ID: 27859417 [Abstract] [Full Text] [Related]
3. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. Lv Z, Wei J, You W, Wang R, Shang J, Xiong Y, Yang H, Yang X, Fu Z. J Transl Med; 2017 Dec 19; 15(1):257. PubMed ID: 29258530 [Abstract] [Full Text] [Related]
4. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop. Sengupta D, Deb M, Rath SK, Kar S, Parbin S, Pradhan N, Patra SK. Exp Cell Res; 2016 Aug 15; 346(2):176-87. PubMed ID: 27475839 [Abstract] [Full Text] [Related]
5. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer. Li J, Ying Y, Xie H, Jin K, Yan H, Wang S, Xu M, Xu X, Wang X, Yang K, Zheng X, Xie L. FASEB J; 2019 Jan 15; 33(1):1374-1388. PubMed ID: 30138038 [Abstract] [Full Text] [Related]
6. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis. Wu T, Qu L, He G, Tian L, Li L, Zhou H, Jin Q, Ren J, Wang Y, Wang J, Kan X, Liu M, Shen J, Guo M, Sun Y. Oncotarget; 2016 Mar 08; 7(10):11553-66. PubMed ID: 26872375 [Abstract] [Full Text] [Related]
7. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo. Shi J, Tan S, Song L, Song L, Wang Y. Biomed Pharmacother; 2020 Jan 08; 121():109620. PubMed ID: 31810117 [Abstract] [Full Text] [Related]
8. miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1. Wang Y, Hu Y, Guo J, Wang L. Genet Test Mol Biomarkers; 2019 Feb 08; 23(2):98-104. PubMed ID: 30735457 [Abstract] [Full Text] [Related]
9. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y, Qi YT, Xu Q, Li W, Lu B, Peiper SS, Jiang BH, Liu LZ. J Mol Cell Biol; 2013 Feb 08; 5(1):3-13. PubMed ID: 22935141 [Abstract] [Full Text] [Related]
10. MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer. Li J, Xu X, Meng S, Liang Z, Wang X, Xu M, Wang S, Li S, Zhu Y, Xie B, Lin Y, Zheng X, Liu B, Xie L. Cell Death Dis; 2017 Aug 24; 8(8):e3010. PubMed ID: 28837140 [Abstract] [Full Text] [Related]
11. miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1. Lombard AP, Mooso BA, Libertini SJ, Lim RM, Nakagawa RM, Vidallo KD, Costanzo NC, Ghosh PM, Mudryj M. Mol Carcinog; 2016 May 24; 55(5):757-67. PubMed ID: 25865490 [Abstract] [Full Text] [Related]
12. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA. Lv M, Zhong Z, Huang M, Tian Q, Jiang R, Chen J. Biochim Biophys Acta Mol Cell Res; 2017 Oct 24; 1864(10):1887-1899. PubMed ID: 28779971 [Abstract] [Full Text] [Related]
13. miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance. Deng X, Liu Z, Liu X, Fu Q, Deng T, Lu J, Liu Y, Liang Z, Jiang Q, Cheng C, Fang W. Mol Ther; 2018 Apr 04; 26(4):1066-1081. PubMed ID: 29525743 [Abstract] [Full Text] [Related]
14. MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met. Xu X, Chen H, Lin Y, Hu Z, Mao Y, Wu J, Xu X, Zhu Y, Li S, Zheng X, Xie L. Mol Cells; 2013 Jul 04; 36(1):62-8. PubMed ID: 23820886 [Abstract] [Full Text] [Related]
15. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling. Liu R, Gu J, Jiang P, Zheng Y, Liu X, Jiang X, Huang E, Xiong S, Xu F, Liu G, Ge D, Chu Y. Clin Cancer Res; 2015 Feb 15; 21(4):854-63. PubMed ID: 25512445 [Abstract] [Full Text] [Related]
16. CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer. Ying Y, Li J, Xie H, Yan H, Jin K, He L, Ma X, Wu J, Xu X, Fang J, Wang X, Zheng X, Liu B, Xie L. Cell Prolif; 2020 Feb 15; 53(2):e12751. PubMed ID: 31971654 [Abstract] [Full Text] [Related]
17. circ_100984-miR-432-3p axis regulated c-Jun/YBX-1/β-catenin feedback loop promotes bladder cancer progression. Tong L, Yang H, Xiong W, Tang G, Zu X, Qi L. Cancer Sci; 2021 Apr 15; 112(4):1429-1442. PubMed ID: 33314480 [Abstract] [Full Text] [Related]
18. miR-148a-3p inhibits the proliferation and migration of bladder cancer via regulating the expression of ROCK-1. Xu C, Zhou G, Sun Z, Zhang Z, Zhao H, Jiang X. PeerJ; 2022 Apr 15; 10():e12724. PubMed ID: 35127282 [Abstract] [Full Text] [Related]
19. c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling. Xu X, Zhu Y, Liang Z, Li S, Xu X, Wang X, Wu J, Hu Z, Meng S, Liu B, Qin J, Xie L, Zheng X. Cell Death Dis; 2016 Feb 04; 7(2):e2088. PubMed ID: 26844702 [Abstract] [Full Text] [Related]
20. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB. Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]